AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Schiscandrin B Preparation草藥製備

Schisandrin B is an extract from a Chinese medicine, which is well known of treating various cardiovascular diseases and many other conditions.

The invention reveals the method of preparation of Schisandrin B, and how to use it in prevention and/or treatment of heart diseases or other related conditions. Such preparation may additionally comprise one or more components selected from the group consisting of herbal extracts, fluids, solvents, antioxidants, preservatives, electrolytes, salts and pH control agents.
Technology Benefits
1. Effective Extraction
2. Controlled concentration
3. Ready in various forms (aqueous, powdered, etc.)
Technology Application
- Applied in drugs
- Additives for foods, beverages
Supplementary Information
Patent Number: US7276257B2
Application Number: US2005188021A
Inventor: Ko, Kam Ming
Priority Date: 22 Jul 2005
Priority Number: US7276257B2
Application Date: 22 Jul 2005
Publication Date: 2 Oct 2007
IPC Current: A61K003679
US Class: 424725
Assignee Applicant: The Hong Kong University of Science & Technology
Title: Schisandrin B preparation
Usefulness: Schisandrin B preparation
Summary: As aqueous herbal preparation or powdered pharmaceutical preparation, for preventing and treating heart condition, liver condition, renal condition, lung condition, cardiovascular condition, myocardial damage or infarction, coronary heart disease, impaired heart-lung function, cancer, heart failure, ischemia, viral myocarditis, septic/hemorrhagic shock, liver failure, chronic hepatitis, chronic bronchitis, gastritis, type II diabetes, toxic side effects arising from cancer chemotherapy, aging and age-related diseases, liver failure, heart failure, Alzheimer's disease, Parkinson's disease, dehydration, failure of organs and muscle damage (all claimed).
Novelty: Pharmaceutical preparation for preventing and treating myocardial infarction, coronary heart disease, cancer, ischemia, septic shock and liver failure, comprises preset amount of Schisandrin B as active ingredient
Disease Diagnostic/Treatment
Sub Category
Application Date
22 Jul 2005
Application No.
US 11/188021
Patent Information
US 7276257
ID No.
Hong Kong

For more information, please click Here
Mobile Device